TGF-β1 869T/C polymorphism and ischemic stroke: Sex difference in Chinese

Canadian Journal of Neurological Sciences

Volumn 37, Issue 6, 2010, Pages 803-807

  Tao, Hong Miao ^a   Chen, Guo Zhong ^a   Lu, Xiao Dong ^b   Chen, Gan Ping ^c   Shao, Bei ^d  

^a Jinhua College of Profession and Technology   (China)

^b Jinhua Central Hospital   (China)

^c Jinhua People's Hospital   (China)

^d First Affiliated Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHINESE; DNA SEQUENCE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 79952974319     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100051477     Document Type: Article

References (32)

1. World Health Organization. The World Health Report: shaping the future. Geneva, Switzerland: WHO; 2003.
2. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain. 2000; 123(Pt 9):1784-812. (Pubitemid 30664283)
3. Libby P. Inflammation in atherosclerosis. Nature. 2002; 420(6917): 868-74. (Pubitemid 36019640)
4. Kim JS, Yoon SS, Kim YH, Ryu JS. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke. 1996;27(9):1553-7. (Pubitemid 26295905)
5. Li D, Liu Y, Chen J, et al. Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice. Biochem Biophys Res Commun. 2006; 344(3): 701-7.
6. Grainger DJ. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol. 2004; 24(3):399-404. (Pubitemid 38326130)
7. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK. Disruption of TGF-βsignaling in T cells accelerates atherosclerosis. J Clin Invest. 2003; 112(9):1342-50. (Pubitemid 38057688)
8. Tashiro H, Shimokawa H, Sadamatu K, Yamamoto K. Prognostic significance of plasma concentrations of transforming growth factor-βin patients with coronary artery disease. Coron Artery Dis. 2002; 13(3):139-43. (Pubitemid 34747960)
9. Bobik A. Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol. 2006; 26(8):1712-20. (Pubitemid 44305323)
10. Singh NN, Ramji DP. The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev. 2006; 17(6): 487-99. (Pubitemid 44793117)
11. Fujii D, Brissenden JE, Derynck R, Francke U. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 1986; 12(3):281-8. (Pubitemid 16040676)
12. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factorbeta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation.1998; 66(8):1014-20. (Pubitemid 28513380)
13. Shah R, Rahaman B, Hurley CK, Posch PE. Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet. 2006; 119(1-2): 61-74.
14. Lu LY, Cheng HH, Sung PK, Yeh JJ, Shiue YL, Chen A. Singlenucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect. 2004; 37(3):145-52. (Pubitemid 38899944)
15. Yang ZX, Wang H, Gao CF, Xu LL, Zhao WJ. Effect of polymorphisms of transforming growth factor B1 gene on HBVinduced liver cirrhosis. Natl Med J China. 2005; 85(15):1021-6. (Pubitemid 40590348)
16. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999; 8(1):93-7. (Pubitemid 29039053)
17. Dunning AM, Ellis PD, McBride S, et al. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res. 2003; 63(10):2610-5. (Pubitemid 36605203)
18. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation. 2000; 101(24): 2783-7 (Pubitemid 30396007)
19. The International HapMap Consortium. The International HapMap Project. Nature. 2003; 426:789-96.
20. Kim Y, Lee C. The gene encoding transforming growth factor beta 1 confers risk of ischemic stroke and vascular dementia. Stroke. 2006; 37(11):2843-5. (Pubitemid 44922550)
21. Sie MP, Uitterlinden AG, Bos MJ, et al. TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study. Stroke. 2006; 37(11):2667-71. (Pubitemid 44922523)
22. Carter AM, Catto AJ, Bamford JM, Grant PJ. Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease.Arterioscler Thromb Vasc Biol. 1997; 17(3):589-94.
23. Schurks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology. 2008; 71(7):505-13.
24. Morrison AC, Ballantyne CM, Bray M, Chambless LE, Sharrett AR, Boerwinkle E. LPL polymorphism predicts stroke risk in men. Genet Epidemiol. 2002; 22(3):233-42. (Pubitemid 34246663)
25. Investigation committee of guideline for diagnosis and treatment of hyperlipemias, Japan Atherosclerosis Society. Guideline for diagnosis and treatment of hyperlipemias in adults. J Jpn Atheroscler Soc. 1997; 25:1-34.
26. World Health Organization Study Group Diabetes mellitus. WHO Tech Rep Ser. 1985; 727:1-104.
27. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acid Res. 1989, 17:2503-16. (Pubitemid 19103235)
28. Fukuda K, Yao H, Ibayashi S, et al. Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats. Stroke. 2000; 31(1):155-60. (Pubitemid 30035769)
29. Santizo RA, Xu HL, Ye S, Baughman VL, Pelligrino DA. Loss of benefit from estrogen replacement therapy in diabetic ovariectomized female rats subjected to transient forebrain ischemia. Brain Res. 2002; 956(1):86-95. (Pubitemid 35335560)
30. Falkeborn M, Persson I, Terent A, Adami HO, Lithell H, Bergstrom R. Hormone replacement therapy and the risk of stroke. Followup of a population-based cohort in Sweden. Arch Intern Med. 1993; 153(10):1201-9. (Pubitemid 23137546)
31. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch Intern Med. 1993; 153(1): 73-9 (Pubitemid 23043371)
32. Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F. Cross-talk between transforming growth factor-B and estrogen receptor signaling through Smad3. J Biol Chem. 2001; 276:42908-14.